59721-29-8
494.5 Da
C20H22N4O5 • CH3SO3H
May be dissolved in DMSO (50 mg/mL) or Water (50 mg/mL)
-20°C
Description
A serine protease inhibitor inhibiting plasmin, kallikrein, thrombin as well as trypsin, which attenuates pancreatic fibrosis1 . Reduces weight gain and improves metabolism in obese rodent models2 . In clinical use (in Japan) for pancreatitis3 . Inhibits influenza virus replication in human tracheal epithelial cells4 . Reduces infection of Calu-3 lung cells by SARS-CoV-2 (responsible for COVID-19) via inhibition of the serine protease TMPRSS2 required for viral spike protein priming5 .
Shown to be effective against coronavirus.
References
• Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice
• The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects
Not for human therapeutic use or for medicinal purposes. For research applications only.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.